Ligand Pharmaceuticals
LGND
LGND
362 hedge funds and large institutions have $3.61B invested in Ligand Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 156 increasing their positions, 92 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less call options, than puts
Call options by funds: $106M | Put options by funds: $147M
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
46% less capital invested
Capital invested by funds: $6.66B → $3.61B (-$3.05B)
Holders
362
Holding in Top 10
6
Calls
$106M
Puts
$147M
Top Buyers
| 1 | +$98.6M | |
| 2 | +$61.2M | |
| 3 | +$35.9M | |
| 4 |
Jennison Associates
New York
|
+$26.1M |
| 5 |
Two Sigma Investments
New York
|
+$25.8M |
Top Sellers
| 1 | -$79.3M | |
| 2 | -$71.4M | |
| 3 | -$42.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$21.8M |